Proteasomal inhibition hypersensitizes differentiated neuroblastoma cells to oxidative damage

Neuroscience Letters

Volumn 399, Issue 1-2, 2006, Pages 27-32

  Lev, Nirit ^a   Melamed, Eldad ^a   Offen, Daniel ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Alpha synuclein; Parkinson's disease; Protein aggregates; Ubiquitin proteasome system

Indexed keywords

ALPHA SYNUCLEIN; FERROUS CHLORIDE; LACTACYSTIN; PROTEASOME; REACTIVE OXYGEN METABOLITE; ROTENONE; UBIQUITIN;

ARTICLE; CELL DEATH; CELL INCLUSION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NERVE DEGENERATION; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; STATISTICAL SIGNIFICANCE; WILD TYPE;

ALPHA-SYNUCLEIN; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYTOPLASM; FERROUS COMPOUNDS; HUMANS; IMMUNOHISTOCHEMISTRY; MOLSIDOMINE; MUTATION; NEUROBLASTOMA; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEASOME ENDOPEPTIDASE COMPLEX; REACTIVE OXYGEN SPECIES; ROTENONE; THIAZOLES; UBIQUITIN;

EID: 33646521299     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.09.086     Document Type: Article

References (26)

1. Ardley H.A., Scott G.B., Rose S.A., Tan N.G.S., and Robinson P.A. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease. J. Neurochem. 90 (2004) 379-391
2. Bennett M.C., Bishop J.F., Leng Y., Chock P.B., Chase T.N., and Mouradian M.M. Degradation of alpha-synuclein by proteasome. J. Biol. Chem. 274 (1999) 33855-33858
3. Cole N.B., Murphy D.D., Lebowitz J., Di Noto L., Levine R.L., and Nussbaum R.L. Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments. J. Biol. Chem. 280 (2005) 9678-9690
4. Forno L.S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55 (1996) 259-272
5. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., and Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290 (2000) 985-989
6. Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2 (2001) 492-501
7. Good P.F., Hsu A., Werner P., Perl D.P., and Olanow C.W. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57 (1998) 338-342
8. Hasegawa T., Matsuzaki M., Takeda A., Kikuchi A., Akita H., Perry G., Smith M.A., and Itoyama Y. Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells. Brain Res. 1013 (2004) 51-59
9. Jenner P., and Olanow C.W. Understanding cell death in Parkinson's disease. Ann. Neurol. 44 (1998) S72-S84
10. Lee M., Hyun D., Halliwell B., and Jenner P. Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J. Neurochem. 76 (2001) 998-1009
11. Leroy E., Boyer R., Auburger G., Leube B., Ulm G., Mezey E., Harta G., Brownstein M.J., Jonnalagada S., Chernova T., Dehijia A., Lavedan C., Gasser T., Steinbavh P.J., Wilkinson K.D., and Polymeropoulos M.H. The ubiquitin pathway in Parkinson's disease. Nature 395 (1998) 451-452
12. Maguire-Zeiss K.A., Short D.W., and Federoff H.J. Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?. Mol. Brain Res. 134 (2005) 18-23
13. McNaught K.S., Belizaire R., Isacson O., Jenner P., and Olanow C.W. Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179 (2003) 38-46
14. McNaught K.S., Belizaire R., Jenner P., Olanow C.W., and Isacson O. Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease. Neurosci. Lett. 326 (2002) 155-158
15. McNaught K.S., and Jenner P. Proteasomal function is impaired in substantia nigra in Parkinson's disease. Neurosci. Lett. 297 (2001) 191-194
16. McNaught K.S., Mytilineou C., Jnobaptiste R., Yabut J., Shashidharan P., Jenner P., and Olanow C.W. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures. J. Neurochem. 81 (2002) 301-306
17. McNaught K.S., Olanow C.W., Halliwell B., Isacson O., and Jenner P. Failure of ubiquitin-proteasome system in Parkinson's disease. Nat. Rev. Neurosci. 2 (2001) 589-594
18. McNaught K.S., Perl D.P., Brownell A.L., and Olanow C.W. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann. Neurol. 56 (2004) 149-162
19. Meredith G.E., Halliday G.M., and Tottedell S. A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease: new insights into Lewy body formation. Parkinsonism Relat. Disord. 10 (2004) 191-202
20. Mytilineou C., McNaught K.S., Shashidharan P., Yabut J., Baptiste R.J., Parnandi A., and Olanow C.W. Inhibition of proteasome activity sensitizes dopamine neurons to protein alterations and oxidative stress. J. Neural. Transm. 111 (2004) 1237-1251
21. Pollanen M.S., Dickson D.W., and Bergeron C. Pathology and biology of the Lewy body. J. Neuropathol. Exp. Neurol. 52 (1993) 183-191
22. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., and Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997) 2045-2047
23. Rideout H.J., Larsen K.E., Sulzer D., and Stefanis L. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells. J. Neurochem. 78 (2001) 899-908
24. Shimura H., Schlossmacher M.G., Hattori N., Frosch M.P., Trockenbacher A., Schneider R., Mizuno Y., Kosik K.S., and Selkoe D.J. Ubiquitination of a new form of alpha-synuclein by Parkin from human brain: implication in Parkinson's disease. Science 28 (2001) 28
25. Seidler A., Hellenbrand W., Robra B.P., Vieregge P., Nischan P., Joerg J., Oertel W.H., Ulm G., and Schneider E. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 46 (1996) 1275-1284
26. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., and Goedert M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95 (1995) 6469-6473